approval · primary record
TRASTUZUMAB-DTTB
FDA · BLA · 2026-04-15
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-04-15 |
| Brand | ONTRUZANT |
| Sponsor | SAMSUNG BIOEPIS CO LTD |
| Route | IV (INFUSION) |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:13.346Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TRASTUZUMAB-DTTB:2026-04-15
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.